In part 4 of this Frontline Forum series, John M. Strasswimmer, MD, PhD; Andrew H. Weinstein, MD; Neal Bhatia, MD; Laura Ferris, MD; and Aaron S. Farberg, MD, discuss solutions for managing and treating patients with basal cell carcinoma.
In this study, the highest infertility rate was seen in the patients living with hidradenitis suppurativa; however, no direct causality was seen for this, with the authors noting diseases and symptoms comprised the only factors with a statistically significant relationship to infertility.
Independent pharmacies are closing at high rates, leaving many communities without essential health care access.
Peter Lio, MD, reflects on current unmet needs in atopic dermatitis and suggests directions for future research and development.
López-Ferrer discussed how to achieve well-being for patients with psoriasis and Koscielny discussed the unique topics of the Skin Academy.
Experts discuss the treatment landscape of generalized pustular psoriasis as well as review difficult cases of GPP.
Jerry Brewer, MD, MS, shared pearls on reasons to avoid or discontinue Mohs surgery and keeping calm with stressed, vulnerable patients.
Arash Mostaghimi, MD, MPH, MPA, provides insights into what clinicians need to know about deuruxolitinib for severe AA.
The poster, which shares results form consensus research on using LODM for hair loss, was awarded 4th place at the 2024 AAD Annual Meeting.
Lisa M. Arkin, MD, shared how early laser treatment and multidisciplinary approaches improves outcomes for vascular anomalies.
By integrating capabilities and services, we can create health experiences that are much more than the sum of their parts.
The investigator in the clinical development program for deuruxolitinib shared data, patient populations to consider, and more in a recent interview.
A 5-month-old girl with a large scalp infantile hemangioma (IH), present since 6 weeks of age, is evaluated in the emergency department for lethargy and pallor.
Continuing the discussion on the case of a 17-year-old patient with moderate acne, Heather Woolery-Lloyd, MD, FAAD, provides an overview of the utilization of clascoterone cream, highlighting the application process and its unique mechanism of action.
FDA approvals of these biosimilars started in 2016, but only 1 such product has successfully launched.
Li discusses microneedling innovations, global techniques, safety, and future trends in dermatology, including integration with RF and PRP.
As a featured clinician in EltaMD’s Derm Day campaign, Mona Gohara, MD, spoke about her connection with the brand and the work being done to unify dermatologists and promote skin health.
CDC advises not to delay shingles vaccination.
Egeberg discusses promising new treatments and insights from recent clinical trials, highlighting significant advancements in chronic hand eczema and atopic dermatitis care presented at the EADV 2024.
The approval of Galderma’s Restylane Eyelight was one of Martin’s top highlights of 2023.
In this CME article, learn more about the interdisciplinary field of psychodermatology and the collaborative health care team necessary for care.
More than 90% of respondents to a recent survey expressed concern about acne’s effect on their adolescent’s mental health and social life.
A 5-month-old girl with a large scalp infantile hemangioma (IH), present since 6 weeks of age, is evaluated in the emergency department for lethargy and pallor.
J.D. Norcross, director of information technology at VitalSkin Dermatology, discusses some myths and best practices with digital passwords you should know to help keep your practice information safer.
Todd L. Sack, MD, shares practice management tips for going green at the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting.